Stefania Chiappini

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Pharmaceuticals (Basel, Switzerland)

Brain sciences

International journal of environmental research and public health

Journal of clinical medicine

University of Hertfordshire (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Hertfordshire Dec 01 2017

United Kingdom

PHD :: Life and medical sciences- Pharmacy, pharmacology and postgraduate medicine

Libera Università Maria Santissima Assunta Jan 24 2017 - Jan 27 2018

Italy

MSC :: Psicologia

Publications

Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, Stefania Chiappini, Giovanni Martinotti, Maria Lucia Calcagni, Gabriele Sani
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, Francesco Di Carlo, Tommaso Piro, Giulia Giovannetti, Arianna Pasino, Mariachiara Vicinelli, Chiara Lorenzini, Mariapia Di Paolo, Maria Pepe, Marco Di Nicola, Valerio Ricci, Mauro Pettorruso, Giovanni Martinotti
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, Francesco Di Carlo, Tommaso Piro, Giulia Giovannetti, Arianna Pasino, Mariachiara Vicinelli, Chiara Lorenzini, Mariapia Di Paolo, Maria Pepe, Marco Di Nicola, Valerio Ricci, Mauro Pettorruso, Giovanni Martinotti
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, Stefania Chiappini, Giovanni Martinotti, Maria Lucia Calcagni, Gabriele Sani
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Clara Cavallotto, Stefania Chiappini, Alessio Mosca, Giacomo D'Andrea, Francesco Di Carlo, Tommaso Piro, Ottavia Susini, Giulia Stefanelli, Andrea Di Cesare, Valerio Ricci, Maria Pepe, Luigi Dattoli, Marco Di Nicola, Mauro Pettorruso, Giovanni Martinotti
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation. Journal of clinical medicine 13 (8) (2024)
Clara Cavallotto, Stefania Chiappini, Alessio Mosca, Giacomo D'Andrea, Francesco Di Carlo, Tommaso Piro, Ottavia Susini, Giulia Stefanelli, Andrea Di Cesare, Valerio Ricci, Maria Pepe, Luigi Dattoli, Marco Di Nicola, Mauro Pettorruso, Giovanni Martinotti
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation. Journal of clinical medicine 13 (8) (2024)
Stefania Chiappini, Rachel Vickers Smith, Daniel R Harris, G Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L Sensi, Fabrizio Schifano
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Stefania Chiappini, Fabrizio Schifano
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Stefania Chiappini, Francesco Di Carlo, Alessio Mosca, Giacomo d'Andrea, Mariapia Di Paolo, Chiara Lorenzini, Maria Grazia Lupica, Gaia Sampogna, Mauro Pettorruso, Andrea Fiorillo, Giovanni Martinotti
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study. Neuropsychiatric disease and treatment 19 (2023)
Stefania Chiappini, Francesco Di Carlo, Alessio Mosca, Giacomo d'Andrea, Mariapia Di Paolo, Chiara Lorenzini, Maria Grazia Lupica, Gaia Sampogna, Mauro Pettorruso, Andrea Fiorillo, Giovanni Martinotti
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study. Neuropsychiatric disease and treatment 19 (2023)
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Maria Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano, Massimo Di Giannantonio
Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines 10 (2) (2022)
John Martin Corkery, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti, Fabrizio Schifano
Alprazolam-related deaths in Scotland, 2004-2020. Journal of psychopharmacology (Oxford, England) 36 (9) (2022)
Nicolo' Schifano, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Paolo Capogrosso, Federico Dehò, Giovanni Martinotti, Fabrizio Schifano
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review. Brain sciences 12 (11) (2022)
Stefania Chiappini, Rachel Vickers Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Daniel R Harris, Fabrizio Schifano
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Stefania Chiappini, Rachel Vickers Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Valerio Ricci, Giovanni Martinotti, Franca Ceci, Stefania Chiappini, Francesco Di Carlo, Julius Burkauskas, Ottavia Susini, Debora Luciani, Diego Quattrone, Domenico de Berardis, Mauro Pettorruso, Giuseppe Maina, Massimo Di Giannantonio
Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms. International journal of environmental research and public health 18 (23) (2021)
Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis
Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. Journal of psychopharmacology (Oxford, England) 35 (6) (2021)
Giovanni Martinotti, Cristina Merino Del Villar, Andrés Garcia Cordoba, Lluís Andrés Tubau, Ivan Castro Sánchez, Francesco Di Carlo, Stefania Chiappini, Mauro Pettorruso, Fabrizio Schifano, Massimo Di Giannantonio
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History. International journal of environmental research and public health 18 (13) (2021)
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo Di Giannantonio, Fabrizio Schifano
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina (Kaunas, Lithuania) 57 (6) (2021)
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo D'Andrea, Roberta Collevecchio, Ilenia Di Muzio, Stefano L Sensi, Massimo Di Giannantonio
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain sciences 11 (7) (2021)
Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database. Brain sciences 10 (2) (2020)
Laura Orsolini, Stefania Chiappini, John M Corkery, Amira Guirguis, Duccio Papanti, Fabrizio Schifano
The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert review of neurotherapeutics 19 (12) (2019)
Fabrizio Schifano, Stefania Chiappini
Pregabalin: A range of misuse-related unanswered questions. CNS neuroscience & therapeutics 25 (5) (2019)
Fabrizio Schifano, Stefania Chiappini, John M Corkery, Amira Guirguis
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. Brain sciences 8 (4) (2018)
Fabrizio Schifano, Stefania Chiappini
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports. PloS one 13 (10) (2018)

Stefania Chiappini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stefania Chiappini